cis-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate

Catalog No. :
ACDFVE702
CAS No. :
364385-64-8
Molecular Formula :
C13H23NO4
Molecular Weight :
257.33

IUPAC Name:methyl (1s,4s)-4-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate

cis-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$76.00Login to see priceIn stockIn stock
25g98%$243.00Login to see priceIn stockIn stock
100g98%$888.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namecis-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate
IUPAC Namemethyl (1s,4s)-4-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylate
MDL No.MFCD21641997
Molecular FormulaC13H23NO4
Molecular Weight257.33
SMILESO=C([C@H]1CC[C@@H](NC(OC(C)(C)C)=O)CC1)OC
InChI KeyRKOQMDUDKCMVFW-AOOOYVTPSA-N
SynonymMETHYL CIS-4-(BOC-AMINO)CYCLOHEXANECARBOXYLATE | METHYL TRANS-4-(TERT-BUTOXYCARBONYLAMINO)CYCLOHEXANECARBOXYLATE | trans-Methyl 4-((tert-butoxycarbonyl)amino)cyclohexanecarboxylate | SY100490 | 146307-51-9 | 364385-64-8 | 503817-57-0
CAS No.364385-64-8

Synthetic Route by SureRoute

1. ACDFVE702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLTHI785 route compound structure diagram
    ACLTHI78561367-16-6 In Stock
  4. Then
  5. ACDFVE702 route product structure diagram
    ACDFVE702364385-64-8 In Stock
Inquiry

2. ACDFVE702 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTXWO910 route compound structure diagram
    ACTXWO91053292-90-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACDFVE702 route product structure diagram
    ACDFVE702364385-64-8 In Stock
Inquiry

Comments (0)